• About us
• Contact

Advertisement

Organisation › Details

NLC Ventures Netherlands B.V.

Since its founding in 2015, NLC has built a portfolio of over 60 healthtech ventures, making it the largest HealthTech venture builder in Europe. The unique NLC approach ‘entrepreneurship at scale’ – allows NLC to find inventions, and create and support ventures that have a life changing impact on patients around the world. Led by winning teams, together with a dedicated network and driven by data and learnings, NLC builds more ventures every year. *

 

	Start	2019-09-06 existent
	Group	NLC Ventures (Group)
	Industry	venture capital
	Industry 2	healthcare
	Person	Millenaar, Bert-Arjan (NLC Ventures 202111 CEO + Founder)
	Region	Amsterdam
	Country	Netherlands
	Street	25 Paasheuvelweg Amsterdam Health & Technology Center, Tower D, 5th Floor
	City	1105 BP Amsterdam
	Tel	+31-20-244-0623
		Address record changed: 2021-11-27
Basic data	Employees	n. a.
		* Document for »About Section«: NLC Ventures Netherlands B.V.. (4/23/21). "Press Release: NLC Successfully Closes €20 Million Equity Financing Round to further Strengthen and Scale Its Venture Building Model". Amsterdam.
		Record changed: 2024-02-12

Advertisement

More documents for NLC Ventures (Group)

• [1] NLC Ventures Netherlands B.V.. (2/2/24). "Press Release: NLC Health Ventures and BioScience Valuation (BSV) Announce Strategic Collaboration". Amsterdam....
• [2] NLC Ventures Netherlands B.V.. (6/26/23). "Press Release: NLC Announces It Has Completed the Initial Close of the NLC Health Impact Fund"....
• [3] NLC Ventures Netherlands B.V.. (10/5/22). "Press Release: Crainio, an NLC Venture, Sets Out to Revolutionise the Measurement of Intracranial Pressure (ICP) by Developing a Non-invasive Measuring Device"....
• [4] NLC Ventures Netherlands B.V.. (9/27/22). "Press Release: BioDGraft, an NLC Venture, Sets Out to Eliminate the Need for Vein Harvesting in Bypass Surgeries, Proposing a Solution that Lasts for Life"....
• [5] NLC Ventures Netherlands B.V.. (9/8/22). "Press Release: AIDO, an NLC venture, Has Made It Its Mission to Bring more Control to Physicians Performing Endoscopic Procedures and Lower the Threshold to Expand Complex Interventions"....
• [6] NLC Ventures Netherlands B.V.. (8/2/22). "Press Release: Haermonics Series A Funding Offers Pure™ Promise for Future Heart Surgery Patients". Eindhoven....
• [7] NLC Ventures Netherlands B.V.. (5/23/22). "Press Release: Allergios Closes Their Latest Round of Seed Financing"....
• [8] NLC Ventures Netherlands B.V.. (4/20/22). "Press Release: Charles River Laboratories and NLC Collaborate"....
• [9] NLC Ventures Netherlands B.V.. (4/23/21). "Press Release: NLC Successfully Closes €20 Million Equity Financing Round to further Strengthen and Scale Its Venture Building Model". Amsterdam....
• [10] MLA Diagnostics B.V.. (1/13/20). "Press Release: NLC Closes Momentum, Provides Funding Support for MLA Diagnostics"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.